Clinical Oncology
Volume 18, Issue 4 , Pages 313-319 , May 2006

Movement of the Cervix in After-loading Brachytherapy: Implications for Designing External-beam Radiotherapy Boost Fields

  • U. Hombaiah
    • ,
  • P. Blake

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: U. Hombaiah, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK. Tel: +44-0207-352-8171.
    • ,
  • M. Bidmead

Received 14 October 2004 ,Revised 24 September 2005 ,Accepted 9 December 2005.

References 

  1. Blake P, Lambert H, Crawford R. Cancer of the cervix. Gynaecological oncology: a guide to clinical management. New York: Oxford Medical Publications; 1998;45–75
  2. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:870–873
  3. Thomas GM. Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy. N Engl J Med. 1999;340:1198–1200
  4. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer. N Engl J Med. 1999;340:1137–1143
  5. Perez CA, Brady LW, Halperin EC, Ullrich RS. Cancer cervix. Principles and practice of radiation oncology. Chichester, UK: Lippincott Williams and Wilkins; 2004;1000–1915
  6. Wolfson AH, Abdel-Wahab M, Markoe AM, et al. A quantitative assessment of standardised vs. customised midline shield construction for invasive cervical carcinoma. Int J Radiat Oncol Biol Phys. 1997;37:237–242
  7. Todd MC, Maredith WJ. A dosage system for use in the treatment of cancer of uterine cervix. Br J Radiol. 1938;11:809–823
  8. Datta NR, Maria Das KJ, Halder S, Ayyagari S. Midline shield for radiation therapy of carcinoma of the uterine cervix: should it be “midline” or “individualised”?. Med Dosim. 1997;22:139–145
  9. Lee CM, Shrieve DC, Gaffeney DK. Rapid involution and mobility of carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2004;58:625–630
  10. ICRU Report 38 . Dose and volume specification for reporting intracavitary therapy in gynaecology. Bethesda, MD: International Commission on Radiation Units and Measurements; 1985;
  11. Clifton Ling C, Smith AR, Hanlon AL, Owen JB, Brickner TJ, Hanks GE. Treatment planning for carcinoma of the cervix: a patterns of care study report. Int J Radiat Oncol Biol Phys. 1996;34:13–19
  12. Popple RA, Kim RY, Pareek P, Duan J, Shen S, Ivan A. Custom step wedge blocking using dynamic multileaf collimation for parametrial pelvic boost irradiation following brachytherapy for the carcinoma of the cervix. Med Phys. 2003;30:2699–2702
  13. Kim CR, Eaton BA, Steven KR. Localisation of the apex of vagina: implications for radiotherapy planning. Radiology. 1999;212:155–158
  14. Kim RY, Meyer JT, Plott WE, et al. Major geometric variations between multiple high dose rate applications of brachytherapy in the cancer of the cervix: frequency and types of variations. Radiology. 1995;195:419–422
  15. Datta NR, Basu R, Das KJ, Rajashekar D, Pandey CM, Ayyagiri S. Problems in reporting doses and volumes during multiple high dose rate intracavitary brachytherapy for carcinoma cervix as per ICRU report 38: a comparative study using flexible and rigid applicators. Gynecol Oncol. 2003;91:285–292
  16. Bahena JH, Martinez A, Yan D, et al. Spatial reproducibility of the ring and tandem high dose rate cervix applicator. Int J Radiat Oncol Biol Phys. 1998;41:13–19
  17. Datta NR, Basu R, Maria Das KJ, et al. Problems and uncertainities with multiple point ‘A’s during multiple high-dose rate intracavitary brachytherapy in carcinoma cervix. Clin Oncol. 2004;16:129–137
  18. Kim RY, Mc Ginnis LS, Spencer SA, Meredith RF, Jennelle RL, Salter MM. Conventional four-field pelvic radiotherapy technique without CT treatment planning in cancer of the cervix: potential geographic miss. Radiother Oncol. 1994;30:140–145
  19. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005;62:131–137

PII: S0936-6555(05)00516-9

doi: 10.1016/j.clon.2005.12.004

Clinical Oncology
Volume 18, Issue 4 , Pages 313-319 , May 2006

Article Tools

* Image Usage & Resolution